Long lasting drug formulations
First Claim
Patent Images
1. A viral vector comprising a nucleic acid sequence encoding erythropoietin comprising a nucleotide sequence at least 95% homologous to SEQ ID NO:
- 1.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention is directed to long-lasting erythropoietin therapeutic formulations and their methods of use wherein the formulation comprises a genetically modified micro-organ that comprises a vector which comprises a nucleic acid sequence operably linked to one or more regulatory sequences, wherein the nucleic acid sequence encodes erythropoietin.
-
Citations
6 Claims
- 1. A viral vector comprising a nucleic acid sequence encoding erythropoietin comprising a nucleotide sequence at least 95% homologous to SEQ ID NO:
Specification